AIAA Journal, ISSN 0001-1452, 07/2019, Volume 57, Issue 7, pp. 2774 - 2782
Effects of uniform blowing on a Clark-Y airfoil are investigated experimentally aiming at turbulent friction drag reduction. The uniform blowing is applied on...
TURBULENT-BOUNDARY-LAYERS | VELOCITY | HOT-WIRE ANEMOMETRY | SKIN FRICTION | ENGINEERING, AEROSPACE | Turbulent flow | Flat plates | Friction drag | Reynolds number | Fluid flow | Aerodynamics | Projects | Velocity distribution | Velocity | Friction reduction | Friction | Drag reduction | Drag | Angle of attack | Velocity measurement | Blowing pressure
TURBULENT-BOUNDARY-LAYERS | VELOCITY | HOT-WIRE ANEMOMETRY | SKIN FRICTION | ENGINEERING, AEROSPACE | Turbulent flow | Flat plates | Friction drag | Reynolds number | Fluid flow | Aerodynamics | Projects | Velocity distribution | Velocity | Friction reduction | Friction | Drag reduction | Drag | Angle of attack | Velocity measurement | Blowing pressure
Journal Article
The Prostate, ISSN 0270-4137, 02/2017, Volume 77, Issue 2, pp. 145 - 153
BACKGROUND FOXO3a is a member of the forkhead O transcription factors. FOXO3a induces the factors that contribute to cell cycle arrest and is considered a...
prostate cancer | FOXO3a | YB‐1 | ERK | YB-1 | SURVIVAL | VIRUS-RELATED VIRUS | CELLS | TRANSCRIPTION | SENSITIVITY | INHIBITION | DEREGULATION | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | DEGRADATION | LEUKEMIA | PROGRESSION | Phosphorylation - physiology | Prostatic Neoplasms - metabolism | MAP Kinase Signaling System - physiology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Forkhead Box Protein O3 - biosynthesis | Forkhead Box Protein O3 - genetics | Prostatic Neoplasms - genetics | Cell Line, Tumor | Aged | Y-Box-Binding Protein 1 - genetics | Y-Box-Binding Protein 1 - biosynthesis | DNA binding proteins | Prostate cancer | Analysis | Protein binding
prostate cancer | FOXO3a | YB‐1 | ERK | YB-1 | SURVIVAL | VIRUS-RELATED VIRUS | CELLS | TRANSCRIPTION | SENSITIVITY | INHIBITION | DEREGULATION | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | DEGRADATION | LEUKEMIA | PROGRESSION | Phosphorylation - physiology | Prostatic Neoplasms - metabolism | MAP Kinase Signaling System - physiology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Forkhead Box Protein O3 - biosynthesis | Forkhead Box Protein O3 - genetics | Prostatic Neoplasms - genetics | Cell Line, Tumor | Aged | Y-Box-Binding Protein 1 - genetics | Y-Box-Binding Protein 1 - biosynthesis | DNA binding proteins | Prostate cancer | Analysis | Protein binding
Journal Article
Aquaculture, ISSN 0044-8486, 02/2019, Volume 500, pp. 576 - 585
( ) are rod-shaped, Gram-negative, motile aquatic bacteria that can infect fish and mammals, including humans. Due to the importance of this pathogen for fish...
Teleost | Sepsis | Aeromonosis | Immunodiagnosis | Antibody | VIRUS | QUANTITATION | EGG-YOLK | PASSIVE PROTECTION | FISHERIES | MARINE & FRESHWATER BIOLOGY | IGY ANTIBODIES | CHICKEN | Immunohistochemistry | Immunoglobulins | Analysis | Fishes | Aquaculture industry | Mariculture | Bacteria | Health aspects
Teleost | Sepsis | Aeromonosis | Immunodiagnosis | Antibody | VIRUS | QUANTITATION | EGG-YOLK | PASSIVE PROTECTION | FISHERIES | MARINE & FRESHWATER BIOLOGY | IGY ANTIBODIES | CHICKEN | Immunohistochemistry | Immunoglobulins | Analysis | Fishes | Aquaculture industry | Mariculture | Bacteria | Health aspects
Journal Article
Surgical Endoscopy, ISSN 0930-2794, 6/2014, Volume 28, Issue 6, pp. 1774 - 1778
Although the internal hernias have been a huge topic in the field of bariatric surgery, there were a few reports in gastric cancer. The purpose of this study...
Whirl sign | Medicine & Public Health | Surgery | Gynecology | Hepatology | Gastroenterology | Abdominal Surgery | Complication | Roux-en-Y reconstruction | Gastric cancer | Internal hernia | Proctology | SURGERY | BYPASS | SMALL-BOWEL OBSTRUCTION | CLOSURE | COMPLICATIONS | Mesentery - surgery | Humans | Middle Aged | Herniorrhaphy | Male | Tomography, X-Ray Computed | Hernia - diagnostic imaging | Anastomosis, Roux-en-Y - adverse effects | Intestinal Diseases - diagnostic imaging | Laparoscopy - adverse effects | Gastrectomy - adverse effects | Aged, 80 and over | Hernia - etiology | Adult | Female | Aged | Gastric Bypass - methods | Imaging, Three-Dimensional | Intestinal Diseases - etiology | Stomach Neoplasms - surgery | Anastomosis, Roux-en-Y - methods | Hernia | Obesity | Stomach cancer | Analysis | Cancer
Whirl sign | Medicine & Public Health | Surgery | Gynecology | Hepatology | Gastroenterology | Abdominal Surgery | Complication | Roux-en-Y reconstruction | Gastric cancer | Internal hernia | Proctology | SURGERY | BYPASS | SMALL-BOWEL OBSTRUCTION | CLOSURE | COMPLICATIONS | Mesentery - surgery | Humans | Middle Aged | Herniorrhaphy | Male | Tomography, X-Ray Computed | Hernia - diagnostic imaging | Anastomosis, Roux-en-Y - adverse effects | Intestinal Diseases - diagnostic imaging | Laparoscopy - adverse effects | Gastrectomy - adverse effects | Aged, 80 and over | Hernia - etiology | Adult | Female | Aged | Gastric Bypass - methods | Imaging, Three-Dimensional | Intestinal Diseases - etiology | Stomach Neoplasms - surgery | Anastomosis, Roux-en-Y - methods | Hernia | Obesity | Stomach cancer | Analysis | Cancer
Journal Article
GERONTOLOGY, ISSN 0304-324X, 2019, Volume 65, Issue 4, pp. 397 - 406
Background: Androgen production following exercise has been suggested to contribute anabolic actions of muscle. However, the underlying mechanisms of the...
C/EBP-DELTA | HORMONAL RESPONSES | MYOSTATIN GENE | TESTOSTERONE | TRANSCRIPTION | HEAVY-RESISTANCE | GERIATRICS & GERONTOLOGY | Interleukin 6 | SKELETAL-MUSCLE | Exercise | Proteolysis | RESISTANCE EXERCISE | Androgen receptor | Myostatin | EXPRESSION | MEDIATED REGULATION
C/EBP-DELTA | HORMONAL RESPONSES | MYOSTATIN GENE | TESTOSTERONE | TRANSCRIPTION | HEAVY-RESISTANCE | GERIATRICS & GERONTOLOGY | Interleukin 6 | SKELETAL-MUSCLE | Exercise | Proteolysis | RESISTANCE EXERCISE | Androgen receptor | Myostatin | EXPRESSION | MEDIATED REGULATION
Journal Article
The Prostate, ISSN 0270-4137, 02/2017, Volume 77, Issue 2, pp. 145 - 153
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 12, pp. A1448 - A1448
Journal Article
Heart, ISSN 1355-6037, 02/2017, Volume 103, Issue 4, pp. 307 - 314
ObjectiveWe studied evolving antithrombotic therapy patterns in patients with newly diagnosed non-valvular atrial fibrillation (AF) and ≥1 additional stroke...
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | STROKE PREVENTION | RISK-FACTOR | WARFARIN | TRANSIENT ISCHEMIC ATTACK | GLOBAL ANTICOAGULANT REGISTRY | GUIDELINES | EURO HEART SURVEY | SUBGROUP ANALYSIS | THROMBOEMBOLISM | Prospective Studies | Age Factors | Humans | Middle Aged | Stroke - diagnosis | Male | Fibrinolytic Agents - adverse effects | Time Factors | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Treatment Outcome | Practice Patterns, Physicians' - trends | Guideline Adherence | Atrial Fibrillation - epidemiology | Sex Factors | Aged | Fibrinolytic Agents - administration & dosage | Practice Guidelines as Topic | Stroke (Disease) | Care and treatment | Usage | Atrial fibrillation | Diagnosis | Thrombolytic drugs | Patients | Health aspects | Risk factors | Arrhythmias and Sudden Death | 1506 | Stroke
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2016, Volume 37, Issue 38, pp. 2882 - 2889A
The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the...
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Stroke prevention | Stroke | Anticoagulation | Atrial fibrillation | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | PREVENTION | DEATH | PREVALENCE | RISK STRATIFICATION SCHEMES | ANTITHROMBOTIC TREATMENT | RHYTHM MANAGEMENT | REGISTRY | Clinical Research
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 12/2009, Volume 284, Issue 51, pp. 35273 - 35277
The regulatory circuit controlling cellular protein phosphatase-1 (PP1), an abundant group of Ser/Thr phosphatases, involves phosphorylation of PP1-specific...
CA2+ SENSITIZATION | INTEGRIN-LINKED KINASE | LIGHT-CHAIN PHOSPHATASE | STRUCTURAL BASIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHOSPHOPROTEIN INHIBITOR | MEDIATED ACTIVATION | ARTERIAL SMOOTH-MUSCLE | INDUCED CONTRACTION | UP-REGULATION | MYOSIN PHOSPHATASE | Phosphorylation | Enzyme Inhibitors - metabolism | Signal Transduction | Humans | Phosphoprotein Phosphatases - metabolism | Neoplasms - enzymology | Receptors, Neuropeptide Y - metabolism | Cardiovascular Diseases - enzymology | Neoplasm Proteins - metabolism | Cardiovascular Diseases - genetics | Proteins - genetics | Protein Phosphatase 1 - metabolism | Animals | Phosphoprotein Phosphatases - genetics | Proteins - metabolism | Myosin Type II - metabolism | Neoplasms - genetics | Receptors, Neuropeptide Y - genetics | Myosin-Light-Chain Phosphatase - metabolism | Protein Phosphatase 1 - genetics | Receptors, Neuropeptide Y - antagonists & inhibitors | Myosin Type II - genetics | Enzyme Activation - genetics | Neoplasm Proteins - genetics | Minireviews
CA2+ SENSITIZATION | INTEGRIN-LINKED KINASE | LIGHT-CHAIN PHOSPHATASE | STRUCTURAL BASIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHOSPHOPROTEIN INHIBITOR | MEDIATED ACTIVATION | ARTERIAL SMOOTH-MUSCLE | INDUCED CONTRACTION | UP-REGULATION | MYOSIN PHOSPHATASE | Phosphorylation | Enzyme Inhibitors - metabolism | Signal Transduction | Humans | Phosphoprotein Phosphatases - metabolism | Neoplasms - enzymology | Receptors, Neuropeptide Y - metabolism | Cardiovascular Diseases - enzymology | Neoplasm Proteins - metabolism | Cardiovascular Diseases - genetics | Proteins - genetics | Protein Phosphatase 1 - metabolism | Animals | Phosphoprotein Phosphatases - genetics | Proteins - metabolism | Myosin Type II - metabolism | Neoplasms - genetics | Receptors, Neuropeptide Y - genetics | Myosin-Light-Chain Phosphatase - metabolism | Protein Phosphatase 1 - genetics | Receptors, Neuropeptide Y - antagonists & inhibitors | Myosin Type II - genetics | Enzyme Activation - genetics | Neoplasm Proteins - genetics | Minireviews
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2017, Volume 141, Issue 12, pp. 2480 - 2488
The association between alcohol consumption and bladder cancer risk has been insufficiently investigated in East Asian populations, who frequently have the...
population‐based cohort study | acetaldehyde | flushing | alcohol consumption | bladder cancer | population-based cohort study | POPULATION | DRINKING | SMOKING | POLYMORPHISM | VARIANT | ALDH2 | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | ETHANOL | BEVERAGES | Flushing - metabolism | Japan - epidemiology | Acetaldehyde - metabolism | Prospective Studies | Humans | Middle Aged | Urinary Bladder Neoplasms - etiology | Proportional Hazards Models | Male | Flushing - epidemiology | Alcohol Drinking - adverse effects | Alcohol Drinking - epidemiology | Adult | Female | Aged | Urinary Bladder Neoplasms - epidemiology | Urinary Bladder Neoplasms - metabolism | Enzymes | Oncology, Experimental | Physiological aspects | Drinking of alcoholic beverages | Research | Health aspects | Bladder cancer | Risk factors | Public health | Genetic polymorphisms | Acetaldehyde | Cancer | Consumption | Flushing | Ethanol | Drinking behavior | Health risks | Bladder | Risk | Population studies | Metabolism | Aldehyde dehydrogenase | Alcohol use | Alcohols | Confidence intervals | Carcinogens | Urinary bladder | Alcoholic beverages | Beverages | Health risk assessment | Index Medicus
population‐based cohort study | acetaldehyde | flushing | alcohol consumption | bladder cancer | population-based cohort study | POPULATION | DRINKING | SMOKING | POLYMORPHISM | VARIANT | ALDH2 | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | ETHANOL | BEVERAGES | Flushing - metabolism | Japan - epidemiology | Acetaldehyde - metabolism | Prospective Studies | Humans | Middle Aged | Urinary Bladder Neoplasms - etiology | Proportional Hazards Models | Male | Flushing - epidemiology | Alcohol Drinking - adverse effects | Alcohol Drinking - epidemiology | Adult | Female | Aged | Urinary Bladder Neoplasms - epidemiology | Urinary Bladder Neoplasms - metabolism | Enzymes | Oncology, Experimental | Physiological aspects | Drinking of alcoholic beverages | Research | Health aspects | Bladder cancer | Risk factors | Public health | Genetic polymorphisms | Acetaldehyde | Cancer | Consumption | Flushing | Ethanol | Drinking behavior | Health risks | Bladder | Risk | Population studies | Metabolism | Aldehyde dehydrogenase | Alcohol use | Alcohols | Confidence intervals | Carcinogens | Urinary bladder | Alcoholic beverages | Beverages | Health risk assessment | Index Medicus
Journal Article
PLOS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, p. e0164076
Aims Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of...
STROKE | MORTALITY | MANAGEMENT | SCORE | MULTIDISCIPLINARY SCIENCES | ANTITHROMBOTIC THERAPY | INTENSITY | RISK | ANTICOAGULATION | Antiplatyhelmintic Agents - administration & dosage | Antiplatyhelmintic Agents - therapeutic use | Stroke - prevention & control | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Risk Factors | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - mortality | Female | Registries | Hemorrhage - chemically induced | Antiplatyhelmintic Agents - adverse effects | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Patient outcomes | Atrial fibrillation | Mortality | Anticoagulants | Stroke | Fibrillation | Health risks | Electrocardiography | Antagonists | Patients | Bleeding | Embolism | Risk factors | Vitamin K
STROKE | MORTALITY | MANAGEMENT | SCORE | MULTIDISCIPLINARY SCIENCES | ANTITHROMBOTIC THERAPY | INTENSITY | RISK | ANTICOAGULATION | Antiplatyhelmintic Agents - administration & dosage | Antiplatyhelmintic Agents - therapeutic use | Stroke - prevention & control | Prospective Studies | Anticoagulants - administration & dosage | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Risk Factors | Anticoagulants - therapeutic use | Male | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - mortality | Female | Registries | Hemorrhage - chemically induced | Antiplatyhelmintic Agents - adverse effects | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Patient outcomes | Atrial fibrillation | Mortality | Anticoagulants | Stroke | Fibrillation | Health risks | Electrocardiography | Antagonists | Patients | Bleeding | Embolism | Risk factors | Vitamin K
Journal Article
PLoS One, ISSN 1932-6203, 2018, Volume 13, Issue 1, p. e0191592
BACKGROUND: The factors influencing three major outcomes-death, stroke/systemic embolism (SE), and major bleeding-have not been investigated in a large...
MORTALITY | PERSISTENT | GLUCOSE CONTROL | ORAL ANTICOAGULATION | GUIDELINE-RECOMMENDED THERAPIES | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | 2016 ESC GUIDELINES | OUTCOMES | CHRONIC KIDNEY-DISEASE | CLINICAL-PRACTICE
MORTALITY | PERSISTENT | GLUCOSE CONTROL | ORAL ANTICOAGULATION | GUIDELINE-RECOMMENDED THERAPIES | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | 2016 ESC GUIDELINES | OUTCOMES | CHRONIC KIDNEY-DISEASE | CLINICAL-PRACTICE
Journal Article
European Heart Journal, ISSN 0195-668X, 2018, Volume 39, Issue 6, pp. 464 - 473
Aims: Current atrial fibrillation (AF) guidelines discourage antiplatelet (AP) monotherapy as alternative to anticoagulants (ACs). Why AP only is still used is...
Antiplatelet therapy | Atrial fibrillation | Anticoagulant therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | STROKE PREVENTION | ORAL ANTICOAGULATION | RISK | ASPIRIN | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | MULTIPLE IMPUTATION | CLINICAL-OUTCOMES
Antiplatelet therapy | Atrial fibrillation | Anticoagulant therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | STROKE PREVENTION | ORAL ANTICOAGULATION | RISK | ASPIRIN | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | MULTIPLE IMPUTATION | CLINICAL-OUTCOMES
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2016, Volume 223, pp. 543 - 547
Abstract Objective To compare the distribution of international normalized ratios (INRs) in patients receiving vitamin K antagonist (VKA) for newly diagnosed...
Cardiovascular | Vitamin K antagonist | Atrial fibrillation | International normalized ratio | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MANAGEMENT | HEMORRHAGE | GUIDELINES | RISK | ANTIPLATELET THERAPY | FACTOR-V-LEIDEN | REDUCTION | WARFARIN | JAPANESE PATIENTS | Data Interpretation, Statistical | Prospective Studies | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Atrial Fibrillation - blood | Asia - epidemiology | International Normalized Ratio - statistics & numerical data | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - epidemiology | Internationality | Registries - statistics & numerical data | Anticoagulants - pharmacology | Global Health - statistics & numerical data | Aged, 80 and over | Female | Aged | Comparative analysis | Care and treatment | Medicine, Experimental | Medical research
Cardiovascular | Vitamin K antagonist | Atrial fibrillation | International normalized ratio | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MANAGEMENT | HEMORRHAGE | GUIDELINES | RISK | ANTIPLATELET THERAPY | FACTOR-V-LEIDEN | REDUCTION | WARFARIN | JAPANESE PATIENTS | Data Interpretation, Statistical | Prospective Studies | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Atrial Fibrillation - blood | Asia - epidemiology | International Normalized Ratio - statistics & numerical data | Vitamin K - antagonists & inhibitors | Atrial Fibrillation - epidemiology | Internationality | Registries - statistics & numerical data | Anticoagulants - pharmacology | Global Health - statistics & numerical data | Aged, 80 and over | Female | Aged | Comparative analysis | Care and treatment | Medicine, Experimental | Medical research
Journal Article